CME Group Inc. (NASDAQ:CME) Shares Sold by Transamerica Financial Advisors Inc.

Transamerica Financial Advisors Inc. trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME) by 76.3% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 4,328 shares of the financial services provider’s stock after selling 13,924 shares during the quarter. Transamerica Financial Advisors Inc.’s holdings in CME Group were worth $955,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Harbor Capital Advisors Inc. boosted its holdings in shares of CME Group by 0.6% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after purchasing an additional 45 shares during the last quarter. CVA Family Office LLC boosted its stake in CME Group by 11.8% during the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after buying an additional 46 shares during the last quarter. Lester Murray Antman dba SimplyRich grew its holdings in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 50 shares in the last quarter. Zions Bancorporation N.A. increased its stake in shares of CME Group by 3.7% in the 3rd quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock worth $338,000 after acquiring an additional 54 shares during the last quarter. Finally, Quent Capital LLC boosted its position in shares of CME Group by 10.2% during the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after acquiring an additional 55 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the sale, the director now directly owns 25,067 shares in the company, valued at approximately $5,587,935.64. This represents a 1.57 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 12.01 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,621 shares of company stock worth $3,441,063. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Performance

NASDAQ CME opened at $234.39 on Wednesday. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $84.46 billion, a P/E ratio of 24.65, a P/E/G ratio of 5.29 and a beta of 0.55. The stock has a 50-day moving average of $224.18 and a two-hundred day moving average of $211.37. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $235.18.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.25 earnings per share. As a group, analysts anticipate that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 1.96%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio is currently 48.37%.

Analyst Upgrades and Downgrades

CME has been the subject of several recent analyst reports. Morgan Stanley raised their price objective on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Piper Sandler raised their price target on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Monday, October 28th. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a report on Tuesday, October 8th. Citigroup increased their price objective on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. Finally, TD Cowen began coverage on CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price on the stock. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. According to MarketBeat, CME Group has an average rating of “Hold” and a consensus price target of $224.47.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.